#85 Rahul Ballal: on sickle cell disease

Lewis talks with Dr. Rahul Ballal, CEO at Imara Inc, a biopharmaceutical company. Imara develops novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, and is currently developing IMR-687, a highly selective, potent small molecule inhibitor of PDE9, to treat patients with sickle cell disease. In this episode Rahul gives us insights on sickle cell disease and other hemoglobinopathies. *This episode was recorded live on google hangouts. Show notes: website: https://www.imara.com/ -------------------------------------------------------------------------------­----------------- This episode is supported by Audible: Start your 30 day free trail today! using the following link: bit.ly/2YVdZJU - Auto-renews at £7.99/month after 30 days - 1 book monthly membership - Cancel anytime Take your pick from the world’s largest selection of audiobooks including best sellers, latest releases, sci-fi, fantasy and more. Disclaimer: If you sign up using our link, we make a small percentage and you help to support our podcast for which we are truly grateful. This doesn't affect our opinions.

Om Podcasten

A free audio podcast hosted by British entrepreneur, Lewis Maleh. At a time when a lot of us feel tired by the daily onslaught of grim news, and our phone stops us from having meaningful conversations, DTOYP! takes you on a different journey. We believe that each individual story can illuminate a million more. We have conversations about the major topics people want to talk about from business to science and technology. Our subject is the world, life and human experiences. Discover something incredible - DTOYP!